Dallas, November 13, 2024 — Kimberly-Clark Corporation (NYSE: KMB) has announced the election of Joseph Romanelli as an independent member of its board of directors, effective immediately. This strategic move increases the board's size from twelve to thirteen members, reflecting the company's commitment to strengthening its leadership team.
Joseph Romanelli, currently serving as President of Human Health International for Merck & Co., Inc., brings a wealth of experience in global healthcare leadership. His role at Merck involves overseeing operations in over 75 markets outside the United States, leading a team of 14,000 colleagues. Romanelli's extensive background includes serving as CEO of JiXing Pharmaceuticals in China and holding various strategic roles at MSD and Schering-Plough over a 25-year career.
Mike Hsu, Chairman and CEO of Kimberly-Clark, expressed enthusiasm about Romanelli's addition to the board, stating, "Joe Romanelli is an outstanding addition to the Kimberly-Clark board of directors. As we advance our Powering Care strategy, we will benefit from Joe’s global leadership experience and his expertise in using leading-edge science to save and improve lives around the world."
Kimberly-Clark, known for its trusted brands such as Huggies, Kleenex, and Scott, operates in more than 175 countries and holds leading market positions in approximately 70 countries. The company is committed to sustainable practices and has been recognized as one of the World's Most Ethical Companies by Ethisphere for five consecutive years.
For more information on Kimberly-Clark's latest developments and its 150-year history of innovation, visit their official website.
Should you invest in Kimberly-Clark Corp (KMB, Financial) right now? Before you do it, it’s important to understand the business profitability and stock valuations, and find out what the warning signs are about. See the in-depth Kimberly-Clark Corp (KMB) stock research here.
